Skip to main content
. 2016 Apr 12;353:i1246. doi: 10.1136/bmj.i1246

Table 4.

Hazard ratios for death from any cause as function of serum cholesterol in cohort that received diets for one year or more (n=2355)*

Intervention Control Both groups
All participants
No in group 1179 1176 2355
HR (95% CI), P value:
 Crude† 1.45 (1.27 to 1.66), <0.001 1.44 (1.17 to 1.76), <0.001 1.39 (1.23 to 1.58), <0.001
 Adjusted‡ 1.22 (1.04 to 1.44), 0.016 1.28 (1.09 to 1.51), 0.003 1.22 (1.14 to 1.32), <0.001
 Sensitivity§ 1.20 (1.03 to 1.41), 0.023 1.32 (1.11 to 1.57), 0.002 1.24 (1.15 to 1.33), <0.001
Participants aged <65
No in group 886 874 1760
HR (95% CI), P value:
 Crude† 1.02 (0.60 to 1.73), 0.936 1.17 (0.82 to 1.69), 0.389 1.07 (0.93 to 1.23), 0.368
 Adjusted‡ 0.92 (0.61 to 1.37), 0.680 1.12 (0.79 to 1.57), 0.525 1.01 (0.88 to 1.16), 0.924
 Sensitivity§ 0.94 (0.58 to 1.53), 0.816 1.16 (0.79 to 1.70), 0.448 1.02 (0.91 to 1.16), 0.703
Participants aged ≥65
No in group 293 302 595
HR (95% CI), P value:
 Crude† 1.55 (1.39 to 1.71), <0.001 1.53 (1.24 to 1.88), <0.001 1.50 (1.31 to 1.71), <0.001
 Adjusted‡ 1.42 (1.22 to 1.67), <0.001 1.39 (1.10 to 1.76), 0.006 1.35 (1.18 to 1.54), <0.001
 Sensitivity§ 1.36 (1.17 to 1.58), <0.001 1.43 (1.14 to 1.78), 0.002 1.35 (1.19 to 1.53), <0.001

*Cox regressions for death as function of time varying serum cholesterol concentration. All estimates represent hazard ratio for a serum cholesterol decrease of 30 mg/dL (0.78 mmol/L). All models account for clustering within hospital.

†Model adjusted for baseline serum cholesterol concentration.

‡Adjusted for baseline serum cholesterol concentration, age, BMI, sex, adherence to diet, and systolic blood pressure (SBP).

§Further adjusted for time varying percentage change from baseline for BMI and SBP.